TFLL Pharma

Life Sciences Incubator Belgium B. Abis B. Abis /
3590 Diepenbeek
BE
TFLL Pharma
Foundation date
16/09/2016
Sector
#PharmaSubsector
- #Pharma - Drug delivery
- #Pharma - Generics
- #Pharma - Molecular diagnostics
- #Pharma - Peptides
- #Pharma - Small molecule therapeutics
Therapeutic areas
- #Cardiovascular
- #Digestive system
- #Diseases of the nervous system
- #Endocrine - nutritional and metabolic diseases
- #Mental and behavioural disorders
- #Neoplasms / cancer / oncology
- #Respiratory system
TFLL Pharma is a Contract Development Company which develops conventional finished dosage forms and special biotechnological products such as peptides for Pharmaceutical Companies. Expertise Small Molecules Solid dosage forms (Oral) Semi solid dosage and liquid forms (Topical) Parenteral dosage forms (Lyophilized, Liquid and PFS) Liquid dosage forms (Oral suspension and Solution)
Upcoming events
All events-
1212 '23
BioFIT 2023
Event by: Eurasanté -
0602 '24
Discovery to Innovation in Animal Health - 2024
Event by: Ghent University, Provaxs, Paul Dick & Associates -
3011 '23
The GxP Academy: Aseptische Training en werken in LAF/Biosafety Cabinet
Event by: Advipro
Latest news
More news-
argenx reports topline results from ADVANCE-SC study of VYVGART Hytrulo in primary immune thrombocytopenia
19 hours ago
Read more
-
Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansion
Wednesday November 22nd 2023
Read more
-
argenx announces European Commission approval of subcutaneous VYVGART® (efgartigimod alfa) for generalized myasthenia gravis
Thursday November 16th 2023
Read more
Jobs
More jobs-
-
-
27/11/23
Antwerp, Brussels, East Flanders, Hainaut, Liège, Limburg, Luxembourg, Namur, Flemish Brabant, Walloon Brabant, West Flanders, Remote
Project Manager Life Science & IVD
Permanent
Thema Group Belgium
More info?
Ellen Telleir
Communication Coordinator